SUMMARY
Last decades of evidence medicine biomarkers are found for the routine management of patients in the diagnostic process and prognosis. Chronic hear failure represents clinical condition with complex pathophysiology. In the clinical practice estimation of natriuretic peptides appears to be the gold standard among these patients. It has the fixed place also in the recent guidelines. At present also other biomarkers are identified potentially helpful for the patients with chronic heart failure.


Key words: cardiovascular diseases, heart failure, biomarkers, natriuretic peptides.
Lek Obz, 2020, 69 (7 – 8): 261-263


Andrej DUKÁT 1, Juraj PAYER 1, Ján GAJDOŠÍK 2, Milan KRIŠKA 3, Fedor ŠIMKO 4

1 V. interná klinika LF UK a UNB v Bratislave, prednosta prof. MUDr. J. Payer, PhD., MPH, FRCP
2 Neštátna ambulancia pre dospelých v Nových Zámkoch
3 Ústav farmakológie a klinickej farmakológie LF UK v Bratislave, prednostka prof. MUDr. V. Kristová, PhD.
4 Ústav patologickej fyziológie LF UK v Bratislave, prednosta prof. MUDr. F. Šimko, CSc., FESC